Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801

[1]  R. Cunha,et al.  Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber Synapses , 2008, Neuron.

[2]  G. Fisone,et al.  Adenosine A2A receptors and basal ganglia physiology , 2007, Progress in Neurobiology.

[3]  P. Barberger‐Gateau,et al.  The neuroprotective effects of caffeine , 2007, Neurology.

[4]  P. Agostinho,et al.  Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasis , 2007, Brain Research.

[5]  D. Souza,et al.  Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice , 2007, Experimental Neurology.

[6]  Michael Bader,et al.  Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain , 2007, Neurobiology of Learning and Memory.

[7]  M. Hasselmo.  The role of acetylcholine in learning and memory , 2006, Current Opinion in Neurobiology.

[8]  L. Zacharia,et al.  Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production , 2006, Neuroscience.

[9]  K. Fuxe,et al.  Targeting adenosine A2A receptors in Parkinson's disease , 2006, Trends in Neurosciences.

[10]  Yuan-Ye Ma,et al.  Improved spatial recognition memory in mice lacking adenosine A2A receptors , 2006, Experimental Neurology.

[11]  R. Prediger,et al.  Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats Involvement of adenosine A1 and A2A receptors , 2005, Neurobiology of Aging.

[12]  R. Cunha,et al.  Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade , 2005, Purinergic Signalling.

[13]  Roger Kurlan,et al.  A focus on the synapse for neuroprotection in Alzheimer disease and other dementias , 2004, Neurology.

[14]  R. Hughes.  The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory , 2004, Neuroscience & Biobehavioral Reviews.

[15]  K. Fuxe,et al.  Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. , 2004, Parkinsonism & related disorders.

[16]  C. Müller,et al.  Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease. , 2004, The Journal of organic chemistry.

[17]  Manfred Thiel,et al.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.

[18]  C. Dourish,et al.  Potential for antipsychotic and psychotomimetic effects of A2A receptor modulation , 2003, Neurology.

[19]  Diogo R. Lara,et al.  Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice , 2003, Psychopharmacology.

[20]  E. Barrett-Connor,et al.  Coffee consumption and cognitive function among older adults. , 2002, American journal of epidemiology.

[21]  A. de Mendonça,et al.  Does caffeine intake protect from Alzheimer's disease? , 2002, European journal of neurology.

[22]  P. d'Alcantara,et al.  Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission , 2001, Neuroscience.

[23]  T. Stone,et al.  Effects of purine analogues on spontaneous alternation in mice , 1996, Psychopharmacology.

[24]  T. Hasegawa,et al.  The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. , 1996, The Journal of pharmacology and experimental therapeutics.

[25]  J. Sirviö,et al.  The effects of d-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks , 1995, European Neuropsychopharmacology.

[26]  G. Ellison.  The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias , 1995, Brain Research Reviews.

[27]  F. Colpaert,et al.  The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. , 1989, The Journal of pharmacology and experimental therapeutics.

[28]  G. Collingridge.  The role of NMDA receptors in learning and memory , 1987, Nature.

[29]  H. Weingartner,et al.  Human serial learning: enhancement with arecholine and choline impairment with scopolamine. , 1978, Science.

[30]  H. Anisman.  Dissociation of disinhibitory effects of scopolamine: Strain and task factors , 1975, Pharmacology Biochemistry and Behavior.

[31]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[32]  R. Prediger,et al.  Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. , 2008, Frontiers in bioscience : a journal and virtual library.

[33]  P. Svenningsson,et al.  Adenosine and brain function. , 2005, International review of neurobiology.

[34]  M. Lynch,et al.  Long-term potentiation and memory. , 2004, Physiological reviews.

[35]  L. Miller,et al.  Effects of δ9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze , 2004, Psychopharmacologia.